Zellweger syndrome, also known as Zellweger hepatoencephalic syndrome, is a rare and serious disease that affects several systems in the body, including the liver, brain and kidneys. This genetic condition is among a group of disorders known as peroxisome disorders, which affect the body's ability to break down certain lipids and fatty acids. Zellweger syndrome is characterized by a series of symptoms that can vary in severity, from developmental problems to liver and neurological damage.

Causes of Zellweger syndrome Zellweger

Zellweger syndrome is caused by genetic mutations that affect the formation and function of peroxisomes, which are cellular organelles that play an important role in the breakdown of long-chain fatty acids and the synthesis of plasmalogens. These mutations affect the body's ability to properly break down lipids and fatty acids, leading to the accumulation of these compounds in the body's tissues and cells.

Zellweger syndrome is an autosomal recessive disorder, meaning it is inherited when a child receives two copies of the defective gene, one from each parent. Parents who carry the defective gene can pass it on to their children, increasing their risk of developing the disease.

Risk factors

Risk factors for Zellweger syndrome include family history of the disease, since it is an inherited genetic condition. Parents carrying the defective gene have a 25% risk of transmitting the disease to their children. Additionally, couples who have a child with Zellweger syndrome have a higher risk of having another child with the same condition.

Symptoms of Zellweger Syndrome

Symptoms of Zellweger syndrome They can vary in severity and affect various body systems. Some of the common symptoms include:

Developmental problems

  • Delayed motor and cognitive development.
  • Cerebellar hypoplasia (underdeveloped cerebellum) .
  • Hypotonia (low muscle tone).

Liver problems

  • Hepatomegaly (increased liver size).
  • Liver dysfunction.
  • Liver failure.

Facial and eye problems

  • Characteristic facies, including large head and forehead prominent.
  • Strabismus (crossed eyes).
  • Cataracts.

Kidney-related problems

  • Polycystic kidneys (kidney cysts).
  • Kidney dysfunction.

These symptoms usually appear in the first months of life and worsen over time. The severity of symptoms can vary, but Zellweger syndrome is usually a progressive and life-threatening disease.

Diagnosis of Zellweger Syndrome

The diagnosis of Zellweger syndrome is based on clinical evaluation of the patient's symptoms, as well as genetic testing to detect mutations that cause the disease. Some common tests that may be used in the diagnostic process include:

Blood tests

Laboratory tests may be performed to measure the levels of long-chain fatty acids and plasmalogens in blood, which are often elevated in patients with Zellweger syndrome.

Magnetic resonance imaging (MRI)

MRI can be used to evaluate the size and structure of the brain, as well as to identify brain abnormalities that are common in patients with Zellweger syndrome.

Liver biopsy

In some cases, a liver biopsy may be performed to evaluate the degree of liver involvement and confirm the diagnosis of the disease.

It is important that the diagnosis of Zellweger syndrome is made by a specialized medical team, who can provide a comprehensive approach to the treatment and management of the disease.

Treatment of Zellweger Syndrome

Currently, there is no curative treatment for Zellweger syndrome. The focus of treatment is on symptom management and improving the patient's quality of life. Some treatment options that may be used include:

Nutritional support

It is important to ensure that patients receive adequate nutrition, especially those with liver problems that may affect nutrient absorption. In some cases, nutritional supplementation may be necessary.

Management of liver problems

Patients with Zellweger syndrome may require regular follow-up to evaluate liver function and receive treatment to prevent complications such as liver failure. In some severe cases, a liver transplant may be necessary.

Supportive Therapies

Physical, occupational, and speech therapy can help patients develop motor and communication skills , as well as improving their quality of life. Psychological support is also important to help patients and their families cope with the emotional challenges of the disease.

Symptomatic medications

Some medications can be used to control symptoms specific to Zellweger syndrome, such as liver problems, seizures, or muscle spasticity. However, the use of medications must be supervised by a specialized doctor.

The treatment of Zellweger syndrome must be individualized and coordinated by a multidisciplinary medical team that includes pediatricians, hepatologists, neurologists, geneticists and other specialists. according to the patient's needs.

Conclusions

Zellweger syndrome is a rare and serious genetic disease that affects several systems of the body, including the liver, brain and kidneys. Although there is no curative treatment for this disease, a comprehensive and multidisciplinary approach can help improve patients' quality of life and manage symptoms effectively.

It is essential that patients with Zellweger syndrome receive specialized medical care to ensure accurate diagnosis and proper management of the disease. Emotional and psychological support for both patients and their families also plays a crucial role in the management of this progressive and life-threatening disease.